Szczepanski T - Search Results

1

Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol.

Stutterheim J, van der Sluis IM, de Lorenzo P, Alten J, Ancliffe P, Attarbaschi A, Brethon B, Biondi A, Campbell M, Cazzaniga G, Escherich G, Ferster A, Kotecha RS, Lausen B, Li CK, Lo Nigro L, Locatelli F, Marschalek R, Meyer C, Schrappe M, Stary J, Vora A, Zuna J, van der Velden VHJ, Szczepanski T, Valsecchi MG, Pieters R. Stutterheim J, et al. Among authors: szczepanski t. J Clin Oncol. 2021 Feb 20;39(6):652-662. doi: 10.1200/JCO.20.02333. Epub 2021 Jan 6. J Clin Oncol. 2021. PMID: 33405950 Free PMC article.

2

Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia.

Szczepański T, Flohr T, van der Velden VH, Bartram CR, van Dongen JJ. Szczepański T, et al. Best Pract Res Clin Haematol. 2002 Mar;15(1):37-57. doi: 10.1053/beha.2002.0184. Best Pract Res Clin Haematol. 2002. PMID: 11987915 Review.

3

Acute lymphoblastic leukemia.

Hoelzer D, Gökbuget N, Ottmann O, Pui CH, Relling MV, Appelbaum FR, van Dongen JJ, Szczepański T. Hoelzer D, et al. Among authors: szczepanski t. Hematology Am Soc Hematol Educ Program. 2002:162-92. doi: 10.1182/asheducation-2002.1.162. Hematology Am Soc Hematol Educ Program. 2002. PMID: 12446423 Review.

4

Assessment of chosen parameters of the immune system in children with acute lymphoblastic leukemia.

Mazur B, Olejnik I, Wylezol I, Sonta-Jakimczyk D, Szczepanski T, Karpe J. Mazur B, et al. Among authors: szczepanski t. Pediatr Hematol Oncol. 2003 Jun;20(4):303-8. Pediatr Hematol Oncol. 2003. PMID: 12746162

5

Assessment of clonal stability of minimal residual disease targets between 1st and 2nd relapse of childhood precursor B-cell acute lymphoblastic leukemia.

Guggemos A, Eckert C, Szczepanski T, Hanel C, Taube T, van der Velden VH, Graf-Einsiedel H, Henze G, Seeger K. Guggemos A, et al. Among authors: szczepanski t. Haematologica. 2003 Jul;88(7):737-46. Haematologica. 2003. PMID: 12857551 Clinical Trial.

6

[Minimal residual disease in childhood acute lymphoblastic leukemia: diagnosis of the 21 century].

Szczepański T, Sońta-Jakimczyk D, Van Dongen JJ. Szczepański T, et al. Przegl Lek. 2003;60 Suppl 5:1-4. Przegl Lek. 2003. PMID: 14574999 Polish.

7

Classification systems for acute and chronic leukaemias.

Szczepański T, van der Velden VH, van Dongen JJ. Szczepański T, et al. Best Pract Res Clin Haematol. 2003 Dec;16(4):561-82. doi: 10.1016/s1521-6926(03)00086-0. Best Pract Res Clin Haematol. 2003. PMID: 14592643

8

Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells.

Szczepanski T, van der Velden VH, Hoogeveen PG, de Bie M, Jacobs DC, van Wering ER, van Dongen JJ. Szczepanski T, et al. Blood. 2004 May 15;103(10):3798-804. doi: 10.1182/blood-2003-08-2952. Epub 2003 Dec 4. Blood. 2004. PMID: 14656882 Free article.

9

Acute lymphoblastic leukemia followed by a clonally-unrelated EBV-positive non-Hodgkin lymphoma and a clonally-related myelomonocytic leukemia cutis.

Szczepański T, de Vaan GA, Beishuizen A, Bogman J, Jansen MW, van Wering ER, van Dongen JJ. Szczepański T, et al. Pediatr Blood Cancer. 2004 Apr;42(4):343-9. doi: 10.1002/pbc.10466. Pediatr Blood Cancer. 2004. PMID: 14966831

10

Concentration of IL-2, IL-6, IL-8, IL-10 and TNF-alpha in children with acute lymphoblastic leukemia after cessation of chemotherapy.

Mazur B, Mertas A, Sońta-Jakimczyk D, Szczepański T, Janik-Moszant A. Mazur B, et al. Among authors: szczepanski t. Hematol Oncol. 2004 Mar;22(1):27-34. doi: 10.1002/hon.725. Hematol Oncol. 2004. PMID: 15152368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

238 results

Search Page